Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Xinquan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0779-8708; OpenAlex author ID A5101619394. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2018: 2 papers · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 7

  1. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma. Last author DOI 10.1007/s10863-022-09949-0↗
  2. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer. Co-author DOI 10.1111/jcmm.15718↗
  3. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. First author DOI 10.1016/j.prp.2019.152666↗
  4. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613. Co-author DOI 10.1111/jcmm.14467↗
  5. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. Co-author DOI 10.1177/1533033819887962↗
  6. Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis. Co-author DOI 10.1111/cas.13733↗
  7. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Co-author DOI 10.5114/aoms.2018.72564↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huihua Cai · 4 shared papers, 2018–2022 · strength 0.41
  2. Zipeng Lu · 3 shared papers, 2019–2020 · strength 0.26
  3. Meng Cao · 3 shared papers, 2019–2020 · strength 0.26
  4. Tianfang Xia · 3 shared papers, 2019–2020 · strength 0.26
  5. Guodong Shi · 3 shared papers, 2019–2020 · strength 0.26
  6. Pengbo Zhang · 3 shared papers, 2019–2020 · strength 0.26
  7. Yi Miao · 3 shared papers, 2019–2020 · strength 0.26
  8. Baobao Cai · 3 shared papers, 2019–2020 · strength 0.26
  9. Kuirong Jiang · 3 shared papers, 2019–2020 · strength 0.26
  10. Xuemin Chen · 2 shared papers, 2018–2022 · strength 0.24
  11. Lei Chen · 2 shared papers, 2019–2020 · strength 0.17
  12. Pengfei Wu · 2 shared papers, 2019–2020 · strength 0.17
  13. Jingjing Zhang · 2 shared papers, 2019 · strength 0.17
  14. Yong An · 2 shared papers, 2018 · strength 0.16
  15. Di Wu · 1 shared paper, 2022 · strength 0.16
  16. Yue Zhang · 1 shared paper, 2022 · strength 0.16
  17. Yong Yang · 1 shared paper, 2019 · strength 0.09
  18. Peng‐cheng Deng · 1 shared paper, 2019 · strength 0.09
  19. Shouji Cao · 1 shared paper, 2020 · strength 0.09
  20. Qun Chen · 1 shared paper, 2020 · strength 0.09
  21. Lei Xu · 1 shared paper, 2020 · strength 0.09
  22. Pengfei Wu · 1 shared paper, 2019 · strength 0.09
  23. Baoqiang Wu · 1 shared paper, 2018 · strength 0.08
  24. Xuemin Chen · 1 shared paper, 2018 · strength 0.08
  25. Yue Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.